Skip to main content

The ACTwatch project: monitoring anti-malarial markets in seven countries

ACTwatch is a five-year, multi-country research project to monitor anti-malarial and RDT supply and demand in seven malaria endemic countries using three research components. Methods and results from household and outlet studies are shared through this series in Malaria Journal to provide policy makers with relevant evidence and a comprehensive understanding of the anti-malarial and malaria diagnosis market in these countries.

  1. Indoor residual house spraying (IRS) and long-lasting insecticidal nets (LLINs) are the key front-line malaria vector interventions against Anopheles arabiensis, the sole primary malaria vector in Ethiopia. Unive...

    Authors: Oljira Kenea, Meshesha Balkew, Habte Tekie, Wakgari Deressa, Eskindir Loha, Bernt Lindtjørn and Hans J. Overgaard
    Citation: Malaria Journal 2019 18:182
  2. Plasmodium falciparum has shown multidrug resistance, leading to the necessity for the development of new drugs with novel targets, such as the synthesis of isoprenic precursors, which are excellent targets becau...

    Authors: Valeska S. de Sena Pereira, Flávio da Silva Emery, Lis Lobo, Fátima Nogueira, Jonas I. N. Oliveira, Umberto L. Fulco, Eudenilson L. Albuquerque, Alejandro M. Katzin and Valter F. de Andrade-Neto
    Citation: Malaria Journal 2018 17:482
  3. Continued progress towards global reduction in morbidity and mortality due to malaria requires scale-up of effective case management with artemisinin-combination therapy (ACT). The first case of artemisinin re...

    Authors: Megan Littrell, Hellen Gatakaa, Sochea Phok, Henrietta Allen, Shunmay Yeung, Char Meng Chuor, Lek Dysoley, Duong Socheat, Angus Spiers, Chris White, Tanya Shewchuk, Desmond Chavasse and Kathryn A O'Connell
    Citation: Malaria Journal 2011 10:328
  4. Access to artemisinin-based combination therapy (ACT) remains limited in high malaria-burden countries, and there are concerns that the poorest people are particularly disadvantaged. This paper presents new ev...

    Authors: Megan Littrell, Hellen Gatakaa, Illah Evance, Stephen Poyer, Julius Njogu, Tsione Solomon, Erik Munroe, Steven Chapman, Catherine Goodman, Kara Hanson, Cyprien Zinsou, Louis Akulayi, Jacky Raharinjatovo, Ekundayo Arogundade, Peter Buyungo, Felton Mpasela…
    Citation: Malaria Journal 2011 10:327
  5. Artemisinin-based combination therapy (ACT) is the first-line malaria treatment throughout most of the malaria-endemic world. Data on ACT availability, price and market share are needed to provide a firm evide...

    Authors: Kathryn A O'Connell, Hellen Gatakaa, Stephen Poyer, Julius Njogu, Illah Evance, Erik Munroe, Tsione Solomon, Catherine Goodman, Kara Hanson, Cyprien Zinsou, Louis Akulayi, Jacky Raharinjatovo, Ekundayo Arogundade, Peter Buyungo, Felton Mpasela, Chérifatou Bello Adjibabi…
    Citation: Malaria Journal 2011 10:326
  6. Policy makers, governments and donors are faced with an information gap when considering ways to improve access to artemisinin-based combination therapy (ACT) and malaria diagnostics including rapid diagnostic...

    Authors: Tanya Shewchuk, Kathryn A O'Connell, Catherine Goodman, Kara Hanson, Steven Chapman and Desmond Chavasse
    Citation: Malaria Journal 2011 10:325